Proteos Biotech intends to fulfil its ambitious expansion strategy with the help of an investment fund. The company specialising in the production of recombinant enzymes has reached an agreement with Tresmares Capital to become a shareholder.
Best known for its pbserum brand, the company develops exclusive assets for its clients, with a presence in more than 50 countries. A fundamental pillar of the company's global impact has been its research and development, which enables it to offer exclusive assets to its customers and lead the recombinant enzyme market worldwide.
Proteos Biotech has achieved exponential growth over the last few years and to achieve an even greater territorial expansion it relies on Tresmares Capital. Tresmares Capital is an investment platform backed by Banco Santander that supports the development of small and medium-sized enterprises. Tresmares Capital helps these SMEs in different ways: direct investment in capital or with other financing alternatives.